University of Southern California [clinicaltrials_resource:56c58f9a6dfc18340d3dca8d5c99f27b]
Maria P Aranda, PhD [clinicaltrials_resource:003489f579a0ca5fabb060577a6507ed]Mary Ann Pentz, PhD [clinicaltrials_resource:008a7a3ba41e955095069fac9fc8d221]Ann Mohrbacher [clinicaltrials_resource:034bbebc75f079cb4c334454a2af4fc7]Siamak Daneshmand, MD [clinicaltrials_resource:03b13c794ff7523c866288b7def24917]Thomas A Buchanan, MD [clinicaltrials_resource:042773173719e42b98e53bf99822ea6c]Giselle M Petzinger, MD [clinicaltrials_resource:04653a9fc63ed4d237e0c333e6d8a10d]Sharon Cermak, EdD [clinicaltrials_resource:048cf10e00d2f49539fff20c57c186d6]Antonio Pellicer, MDPhD [clinicaltrials_resource:04d4442faff5f7e35e194ccdd801cc11]Alexandra M. Levine, MD [clinicaltrials_resource:04d54f20ac9d61f15200b5c0c0fa2d3d]Christina Dieli-Conwright [clinicaltrials_resource:0649872b8c8b1d9f9489b881c7963ba8]Parish Sedghizadeh [clinicaltrials_resource:0678664125394a6130b90ec7835a45d7]James Buxbaum, MD [clinicaltrials_resource:06ab1240ec49158b5bcaa8532f85b57d]Leonardo Clavijo, MD, PhD [clinicaltrials_resource:06c4899401139a45ac86a2ee064fbfc0]Siamak Daneshmand [clinicaltrials_resource:080be588720458109886e0bc2e389608]Oscar Streeter, MD [clinicaltrials_resource:0ab076571a2299933f8caf2bac7e0363]James Buxbaum, MD [clinicaltrials_resource:0adbfe9a70453ee9617851a47045544f]Terence Sanger, MD, PhD [clinicaltrials_resource:0aec97f650272b84b96ff23ab5eddd00]Parish Sedghizadeh [clinicaltrials_resource:0b384f5372d6c01dbe8ec45db4df49f3]Heather MacDonald, M.D. [clinicaltrials_resource:0b47f0645f140c7791d4d94a268e8bee]Linda Hovanessian-Larsen [clinicaltrials_resource:0bd55242f5532dbf83b6c38a9c752195]Terence Sanger, MD, PhD [clinicaltrials_resource:0c82f1a9a16033465b81aa38475c001a]Michael M Kline, MD [clinicaltrials_resource:0e5ffd0250a5e7031fa5a07fa58f621b]Sharon Cermak, EdD [clinicaltrials_resource:0e78f0cb677f58a8a68fb6d7871d5fe8]Fred A Weaver, MD [clinicaltrials_resource:0fe0251b074e197a3691d5963ebef4c9]Penina Segall-Gutierrez, M.D., M.Sc. [clinicaltrials_resource:102f5b702d43f18dc7f4575375dc3a2d]Carolee Winstein, PhD, PT, FAPTA [clinicaltrials_resource:10e606305139179a7d502aae90eaf33b]Heather Macdonald [clinicaltrials_resource:111e8332313f7167d34a448bbbe7ecda]Leonardo Clavijo, MD, PhD [clinicaltrials_resource:11845000f5a300dae060c38609f9db42]Inderbir Gill, MD [clinicaltrials_resource:123e6712cccbd1d37fecfd50fdfa99e0]Mitchell Gross [clinicaltrials_resource:12671b1f68b36b6ba7c24aa29a6eb27f]Terence Sanger, MD, PhD [clinicaltrials_resource:138388be009f6459f084a1ff2661fa0c]Marie-Soleil Wagner, MD [clinicaltrials_resource:141846012dd608ff79d84795a6b47d7f]Vinay Duddalwar [clinicaltrials_resource:148ce8bd22a57bee071fc42fe8b50848]Beth E Fisher, PhD, PT [clinicaltrials_resource:14e0a565c64bc9e483d64466e953cbc4]Abraham Kroon, MD, PhD [clinicaltrials_resource:1526800ff7e961797416facd992a3b32]Dilip Parekh, MD [clinicaltrials_resource:16ed35a6ccecfadc7e3b8131665392b7]Andres Weitz [clinicaltrials_resource:175e21c645bb781754a12fcb028b8ae3]Donna Spruijt-Metz, PhD [clinicaltrials_resource:186c3ce2c26a932eed9572e038569025]Syma Iqbal [clinicaltrials_resource:18a28af784e7941ed49793abf44d32fa]Terence Sanger, MD, PhD [clinicaltrials_resource:1a44f50f8bd576c06add959643db8a24]
affiliation [clinicaltrials_vocabulary:affiliation]
Cryosurgery in Treating Patients With Soft Tissue Sarcoma [clinicaltrials:NCT00002863]Combination Chemotherapy in Treating Patients With Advanced Cancer of the Pancreas [clinicaltrials:NCT00002955]Inhaled Interleukin-2 in Treating Patients With Metastatic or Unresectable Cancer [clinicaltrials:NCT00003009]Radiation Therapy Plus Paclitaxel in Treating Patients With Stage IIB or Stage III Breast Cancer [clinicaltrials:NCT00003050]Laparoscopic Ultrasound in Diagnosing Patients With Pancreatic Cancer [clinicaltrials:NCT00003085]Vaccine Therapy in Treating Patients With Stage II Melanoma That Can Be Removed by Surgery [clinicaltrials:NCT00003274]Vaccine Therapy With or Without Interleukin-12 in Treating Patients With Stage III or Stage IV Melanoma [clinicaltrials:NCT00003339]Combination Chemotherapy in Treating Patients With Platinum-Resistant Recurrent Ovarian Cancer [clinicaltrials:NCT00003449]IM-862 in Treating Patients With Recurrent Ovarian Cancer [clinicaltrials:NCT00003773]Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma [clinicaltrials:NCT00005841]Chemotherapy Plus IM-862 in Treating Patients With Metastatic Colorectal Cancer [clinicaltrials:NCT00006037]Vaccine Therapy Followed by Biological Therapy in Treating Patients With Stage III or Stage IV Melanoma [clinicaltrials:NCT00006113]Monoclonal Antibody and Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Has Been Removed During Surgery [clinicaltrials:NCT00025181]Vaccine Therapy and Interleukin-12 With Either Alum or Sargramostim After Surgery in Treating Patients With Melanoma [clinicaltrials:NCT00031733]clinicaltrials:NCT00085189clinicaltrials:NCT00114517Childhood Hypertonia of Central Origin: A Trial of Anticholinergic Treatment Effects [clinicaltrials:NCT00122044]clinicaltrials:NCT00159432Capecitabine and Gemcitabine in Patients With Metastatic Colorectal Cancer [clinicaltrials:NCT00159445]Genes as Predictors of Response to Gemcitabine, Docetaxel, and Capecitabine (GTX) in Metastatic or Unresectable Pancreatic Cancer. [clinicaltrials:NCT00159471]Phase I/II Study of Celebrex and EPO906 in Patients With Metastatic Colorectal Cancer [clinicaltrials:NCT00159484]Trial of Liposomal Doxorubicin (Doxil) and Weekly Docetaxel (Taxotere) [clinicaltrials:NCT00183742]clinicaltrials:NCT00183794A Study of Irinotecan, Cisplatin and Celebrex in Patients With Metastatic or Unresectable Esophageal Cancer [clinicaltrials:NCT00183807]Study of Gemcitabine, Oxaliplatin, and Paclitaxel in Patients With Refractory Germ Cell Carcinoma [clinicaltrials:NCT00183820]Study of Xeloda and Gleevec in Patients With Advanced Solid Tumors [clinicaltrials:NCT00183833]Study of Irinotecan and Docetaxel in Patients With Metastatic or Unresectable Gastric or Gastroesophageal Junction Adenocarcinoma [clinicaltrials:NCT00183872]Study of Oxaliplatin and Xeloda and Cetuximab as First Line Treatment for Metastatic or Unresectable Gastric or Gastroesophageal Junction Cancer [clinicaltrials:NCT00183898]Study of 5-Fluorouracil and Leucovorin and Intra-abdominal Floxuridine Chemoradiation in Patients With Fully Resected Locally Advanced Gastric Adenocarcinoma [clinicaltrials:NCT00183911]Estramustine, Docetaxel, and Carboplatin for Patients With Hormone Refractory Prostate Cancer Progressing After Mitoxantrone-Based Chemotherapy. [clinicaltrials:NCT00183924]Study of Bortezomib and Docetaxel for Patients With Hormone Refractory Prostate Cancer [clinicaltrials:NCT00183937]clinicaltrials:NCT00183963Doxorubicin (Doxil) Combined With Rituxan, Cyclophosphamide, Vincristine and Prednisone in Newly Diagnosed Aggressive Non-Hodgkin's Lymphomas [clinicaltrials:NCT00184002]clinicaltrials:NCT00184028Elsamitrucin (SPP 28090) in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma [clinicaltrials:NCT00184080]Determining Depression Treatment Preferences of Low-Income Latinos in Primary Care Settings [clinicaltrials:NCT00260169]FOLFIRI + Bevacizumab With or Without Dalteparin in First Line Treatment of Advanced Colorectal Cancer [clinicaltrials:NCT00323011]Vaccine Therapy in Treating Patients With Metastatic Melanoma [clinicaltrials:NCT00334776]Vorinostat and IV Fluorouracil/Leucovorin (5FU/LV) in Patients With Metastatic Colorectal Cancer [clinicaltrials:NCT00336141]Investigator Initiated Study of the Effects of Androgen Therapy on Carbohydrate and Lipid Metabolism In Elderly Men [clinicaltrials:NCT00365794]
collaborator [clinicaltrials_vocabulary:collaborator]
Prospective Comparison of Ampicillin / Amoxicillin Versus Ceftriaxone for the Treatment of Salmonella Infections in AIDS Patients [clinicaltrials:NCT00002052]Cryosurgery in Treating Patients With Soft Tissue Sarcoma [clinicaltrials:NCT00002863]Combination Chemotherapy in Treating Patients With Advanced Cancer of the Pancreas [clinicaltrials:NCT00002955]Inhaled Interleukin-2 in Treating Patients With Metastatic or Unresectable Cancer [clinicaltrials:NCT00003009]Radiation Therapy Plus Paclitaxel in Treating Patients With Stage IIB or Stage III Breast Cancer [clinicaltrials:NCT00003050]Laparoscopic Ultrasound in Diagnosing Patients With Pancreatic Cancer [clinicaltrials:NCT00003085]Vaccine Therapy in Treating Patients With Stage II Melanoma That Can Be Removed by Surgery [clinicaltrials:NCT00003274]Vaccine Therapy With or Without Interleukin-12 in Treating Patients With Stage III or Stage IV Melanoma [clinicaltrials:NCT00003339]Combination Chemotherapy in Treating Patients With Platinum-Resistant Recurrent Ovarian Cancer [clinicaltrials:NCT00003449]IM-862 in Treating Patients With Recurrent Ovarian Cancer [clinicaltrials:NCT00003773]Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma [clinicaltrials:NCT00005841]Chemotherapy Plus IM-862 in Treating Patients With Metastatic Colorectal Cancer [clinicaltrials:NCT00006037]Vaccine Therapy Followed by Biological Therapy in Treating Patients With Stage III or Stage IV Melanoma [clinicaltrials:NCT00006113]Monoclonal Antibody and Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Has Been Removed During Surgery [clinicaltrials:NCT00025181]Novel Adjuvants for Peptide-Based Melanoma Vaccines [clinicaltrials:NCT00028431]Vaccine Therapy and Interleukin-12 With Either Alum or Sargramostim After Surgery in Treating Patients With Melanoma [clinicaltrials:NCT00031733]Safety and Efficacy of Targeted Gene Transfer in Colorectal Cancer Metastatic to Liver [clinicaltrials:NCT00035919]clinicaltrials:NCT00085189clinicaltrials:NCT00114517Childhood Hypertonia of Central Origin: A Trial of Anticholinergic Treatment Effects [clinicaltrials:NCT00122044]clinicaltrials:NCT00159432Capecitabine and Gemcitabine in Patients With Metastatic Colorectal Cancer [clinicaltrials:NCT00159445]Clinical Trial of Gemcitabine and Oxaliplatin in Recurrent or Metastatic Breast Cancer [clinicaltrials:NCT00159458]Genes as Predictors of Response to Gemcitabine, Docetaxel, and Capecitabine (GTX) in Metastatic or Unresectable Pancreatic Cancer. [clinicaltrials:NCT00159471]Phase I/II Study of Celebrex and EPO906 in Patients With Metastatic Colorectal Cancer [clinicaltrials:NCT00159484]Trial of Liposomal Doxorubicin (Doxil) and Weekly Docetaxel (Taxotere) [clinicaltrials:NCT00183742]clinicaltrials:NCT00183794A Study of Irinotecan, Cisplatin and Celebrex in Patients With Metastatic or Unresectable Esophageal Cancer [clinicaltrials:NCT00183807]Study of Gemcitabine, Oxaliplatin, and Paclitaxel in Patients With Refractory Germ Cell Carcinoma [clinicaltrials:NCT00183820]Study of Xeloda and Gleevec in Patients With Advanced Solid Tumors [clinicaltrials:NCT00183833]Study of Irinotecan Administered as a Continuous Infusion and Radiation Therapy for Upper Gastrointestinal Cancers [clinicaltrials:NCT00183846]Clinical and Pharmacokinetic Trial of Intra-Abdominal Irinotecan [clinicaltrials:NCT00183859]Study of Irinotecan and Docetaxel in Patients With Metastatic or Unresectable Gastric or Gastroesophageal Junction Adenocarcinoma [clinicaltrials:NCT00183872]A Phase II Study of Intra-arterial Chemotherapy With Cisplatin and Mitomycin-C in Patients With Hepatocellular Carcinoma [clinicaltrials:NCT00183885]Study of Oxaliplatin and Xeloda and Cetuximab as First Line Treatment for Metastatic or Unresectable Gastric or Gastroesophageal Junction Cancer [clinicaltrials:NCT00183898]Study of 5-Fluorouracil and Leucovorin and Intra-abdominal Floxuridine Chemoradiation in Patients With Fully Resected Locally Advanced Gastric Adenocarcinoma [clinicaltrials:NCT00183911]Estramustine, Docetaxel, and Carboplatin for Patients With Hormone Refractory Prostate Cancer Progressing After Mitoxantrone-Based Chemotherapy. [clinicaltrials:NCT00183924]Study of Bortezomib and Docetaxel for Patients With Hormone Refractory Prostate Cancer [clinicaltrials:NCT00183937]Study of Noscapine for Patients With Low Grade Non Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia Refractory to Chemotherapy [clinicaltrials:NCT00183950]clinicaltrials:NCT00183963
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
Malcolm C. Pike Ph.D., USC Professor, University of Southern California [clinicaltrials_resource:13b2e44ea9c287df2c7e1bc28563fb94]E. Todd Schroeder, PhD, Assistant Professor, University of Southern California [clinicaltrials_resource:13d9be1fd8b4bc5c9ae60f8832d3a95b]George Salem / Associate Professor, University of Southern California [clinicaltrials_resource:14adcadbb89b775d52e252474e82efb5]Loren Laine, University of Southern California [clinicaltrials_resource:1c226963231a2ea37f006d2b289eb9b6]Sanjay Arora MD, University of Southern California [clinicaltrials_resource:24bae62e05f4d9c93a6c9ab25d3c29b7]Dr. Dan Douer, University of Southern California [clinicaltrials_resource:3279890e6710da6158e4ba2023b4a054]Syma Iqbal, MD, University of Southern California [clinicaltrials_resource:3459bdc7d30cb96049d7a40113a169a4]Fred R. Sattler, MD, University of Southern California [clinicaltrials_resource:377699a481b4788bde78be6e2ae1070f]Rangasamy Ramanathan, MD., University of Southern California [clinicaltrials_resource:6d164aaac17a6660304ec2e498a62180]Dr. Barbara Gitlitz, University of Southern California [clinicaltrials_resource:79546416278cd391d92e4061bd826727]Michael Goran/Principal Investigator, University of Southern California [clinicaltrials_resource:7bb8cffbe3c52293c9cb06422d011e88]Beth Fisher, University of Southern California [clinicaltrials_resource:7ffe53617576d61ec23421787f9ac0e3]E. Todd Schroeder Assistant Professor, University of Southern California [clinicaltrials_resource:9b2d2d23eb1dfba7076de97e16294c7f]Agustin Garcia, MD, University of Southern California [clinicaltrials_resource:a05cafda06f7a7fe94beed0f87f470a8]Leonardo Clavijo, MD, PhD, University of Southern California [clinicaltrials_resource:c18f9101bb0b0c10da45254b6ecc0ad2]Barbara Gitlitz, MD, University of Southern California [clinicaltrials_resource:cb4a89c0563dd6ec270936c8a73c5ce2]Mary Ann Pentz, University of Southern California [clinicaltrials_resource:cbff6ca1005140e9130217a133856139]Howard N. Hodis, University of Southern California [clinicaltrials_resource:e9498b269f7388f754e1cdd9cb7b5827]
organization [clinicaltrials_vocabulary:organization]
Cryosurgery in Treating Patients With Soft Tissue Sarcoma [clinicaltrials:NCT00002863]Combination Chemotherapy in Treating Patients With Advanced Cancer of the Pancreas [clinicaltrials:NCT00002955]Inhaled Interleukin-2 in Treating Patients With Metastatic or Unresectable Cancer [clinicaltrials:NCT00003009]Radiation Therapy Plus Paclitaxel in Treating Patients With Stage IIB or Stage III Breast Cancer [clinicaltrials:NCT00003050]Laparoscopic Ultrasound in Diagnosing Patients With Pancreatic Cancer [clinicaltrials:NCT00003085]Vaccine Therapy in Treating Patients With Stage II Melanoma That Can Be Removed by Surgery [clinicaltrials:NCT00003274]Vaccine Therapy With or Without Interleukin-12 in Treating Patients With Stage III or Stage IV Melanoma [clinicaltrials:NCT00003339]Combination Chemotherapy in Treating Patients With Platinum-Resistant Recurrent Ovarian Cancer [clinicaltrials:NCT00003449]IM-862 in Treating Patients With Recurrent Ovarian Cancer [clinicaltrials:NCT00003773]Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma [clinicaltrials:NCT00005841]Chemotherapy Plus IM-862 in Treating Patients With Metastatic Colorectal Cancer [clinicaltrials:NCT00006037]Vaccine Therapy Followed by Biological Therapy in Treating Patients With Stage III or Stage IV Melanoma [clinicaltrials:NCT00006113]Monoclonal Antibody and Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Has Been Removed During Surgery [clinicaltrials:NCT00025181]Novel Adjuvants for Peptide-Based Melanoma Vaccines [clinicaltrials:NCT00028431]Vaccine Therapy and Interleukin-12 With Either Alum or Sargramostim After Surgery in Treating Patients With Melanoma [clinicaltrials:NCT00031733]Safety and Efficacy of Targeted Gene Transfer in Colorectal Cancer Metastatic to Liver [clinicaltrials:NCT00035919]clinicaltrials:NCT00085189clinicaltrials:NCT00114517Childhood Hypertonia of Central Origin: A Trial of Anticholinergic Treatment Effects [clinicaltrials:NCT00122044]clinicaltrials:NCT00159432Capecitabine and Gemcitabine in Patients With Metastatic Colorectal Cancer [clinicaltrials:NCT00159445]Clinical Trial of Gemcitabine and Oxaliplatin in Recurrent or Metastatic Breast Cancer [clinicaltrials:NCT00159458]Genes as Predictors of Response to Gemcitabine, Docetaxel, and Capecitabine (GTX) in Metastatic or Unresectable Pancreatic Cancer. [clinicaltrials:NCT00159471]Phase I/II Study of Celebrex and EPO906 in Patients With Metastatic Colorectal Cancer [clinicaltrials:NCT00159484]Trial of Liposomal Doxorubicin (Doxil) and Weekly Docetaxel (Taxotere) [clinicaltrials:NCT00183742]clinicaltrials:NCT00183794A Study of Irinotecan, Cisplatin and Celebrex in Patients With Metastatic or Unresectable Esophageal Cancer [clinicaltrials:NCT00183807]Study of Gemcitabine, Oxaliplatin, and Paclitaxel in Patients With Refractory Germ Cell Carcinoma [clinicaltrials:NCT00183820]Study of Xeloda and Gleevec in Patients With Advanced Solid Tumors [clinicaltrials:NCT00183833]Study of Irinotecan Administered as a Continuous Infusion and Radiation Therapy for Upper Gastrointestinal Cancers [clinicaltrials:NCT00183846]Clinical and Pharmacokinetic Trial of Intra-Abdominal Irinotecan [clinicaltrials:NCT00183859]Study of Irinotecan and Docetaxel in Patients With Metastatic or Unresectable Gastric or Gastroesophageal Junction Adenocarcinoma [clinicaltrials:NCT00183872]A Phase II Study of Intra-arterial Chemotherapy With Cisplatin and Mitomycin-C in Patients With Hepatocellular Carcinoma [clinicaltrials:NCT00183885]Study of Oxaliplatin and Xeloda and Cetuximab as First Line Treatment for Metastatic or Unresectable Gastric or Gastroesophageal Junction Cancer [clinicaltrials:NCT00183898]Study of 5-Fluorouracil and Leucovorin and Intra-abdominal Floxuridine Chemoradiation in Patients With Fully Resected Locally Advanced Gastric Adenocarcinoma [clinicaltrials:NCT00183911]Estramustine, Docetaxel, and Carboplatin for Patients With Hormone Refractory Prostate Cancer Progressing After Mitoxantrone-Based Chemotherapy. [clinicaltrials:NCT00183924]Study of Bortezomib and Docetaxel for Patients With Hormone Refractory Prostate Cancer [clinicaltrials:NCT00183937]Study of Noscapine for Patients With Low Grade Non Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia Refractory to Chemotherapy [clinicaltrials:NCT00183950]clinicaltrials:NCT00183963Pegylated Liposomal Doxorubicin (Doxil) With Rituximab in Relapsed AIDS-Related Non-Hodgkin's Lymphomas [clinicaltrials:NCT00183976]
source [clinicaltrials_vocabulary:source]
University of Southern California [clinicaltrials_resource:56c58f9a6dfc18340d3dca8d5c99f27b]
Bio2RDF identifier
56c58f9a6dfc18340d3dca8d5c99f27b
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:56c58f9a6dfc18340d3dca8d5c99f27b
organization [clinicaltrials_vocabulary:organization]
identifier
clinicaltrials_resource:56c58f9a6dfc18340d3dca8d5c99f27b
title
University of Southern California
@en
type
label
University of Southern Califor ...... 58f9a6dfc18340d3dca8d5c99f27b]
@en